109 related articles for article (PubMed ID: 7918932)
21. Comparison of single-dose and 7-day fluconazole treatment of fungal esophagitis in alcoholic liver disease.
Péter Z; Horváth Z; Makara M; Telegdy L; Zala J; Zágoni T
Z Gastroenterol; 1996 Jun; 34(6):361-4. PubMed ID: 8767824
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus and Candida esophagitis in patients with AIDS.
Laine L; Bonacini M; Sattler F; Young T; Sherrod A
J Acquir Immune Defic Syndr (1988); 1992; 5(6):605-9. PubMed ID: 1316961
[TBL] [Abstract][Full Text] [Related]
23. Fungemia due to fluconazole-resistant Candida albicans in a patient with AIDS.
Laguna F; Rodríguez-Tudela JL; Enríquez A
Clin Infect Dis; 1994 Sep; 19(3):542-3. PubMed ID: 7811876
[No Abstract] [Full Text] [Related]
24. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
Parente F; Ardizzone S; Cernuschi M; Antinori S; Esposito R; Moroni M; Lazzarin A; Bianchi Porro G
Am J Gastroenterol; 1994 Mar; 89(3):416-20. PubMed ID: 8122656
[TBL] [Abstract][Full Text] [Related]
25. Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study.
Agresti MG; de Bernardis F; Mondello F; Bellocco R; Carosi GP; Caputo RM; Milazzo F; Chiodo F; Giannini V; Minoli L
Eur J Epidemiol; 1994 Feb; 10(1):17-22. PubMed ID: 7957784
[TBL] [Abstract][Full Text] [Related]
26. Presumptive clinical criteria versus endoscopy in the diagnosis of Candida esophagitis at various HIV-1 disease stages.
Antinori A; Antinori A; Ammassari A; Masetti R; De Luca A; Murri R; Tamburrini E; Magistrelli P
Endoscopy; 1995 Jun; 27(5):371-6. PubMed ID: 7588351
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
28. Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Skiest DJ; Vazquez JA; Anstead GM; Graybill JR; Reynes J; Ward D; Hare R; Boparai N; Isaacs R
Clin Infect Dis; 2007 Feb; 44(4):607-14. PubMed ID: 17243069
[TBL] [Abstract][Full Text] [Related]
29. The natural history of esophageal candidiasis after successful treatment in patients with AIDS.
Laine L
Gastroenterology; 1994 Sep; 107(3):744-6. PubMed ID: 8076760
[TBL] [Abstract][Full Text] [Related]
30. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
[TBL] [Abstract][Full Text] [Related]
31. Prospective evaluation of blind brushing of the esophagus for Candida esophagitis in patients with human immunodeficiency virus infection.
Bonacini M; Laine L; Gal AA; Lee MH; Martin SE; Strigle S
Am J Gastroenterol; 1990 Apr; 85(4):385-9. PubMed ID: 2327379
[TBL] [Abstract][Full Text] [Related]
32. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
Stevens DA; Greene SI; Lang OS
Arch Intern Med; 1991 Dec; 151(12):2458-64. PubMed ID: 1747004
[TBL] [Abstract][Full Text] [Related]
33. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
[TBL] [Abstract][Full Text] [Related]
34. Extensive esophageal candidiasis in the absence of oral lesions in pediatric AIDS.
Braegger CP; Albisetti M; Nadal D
J Pediatr Gastroenterol Nutr; 1995 Jul; 21(1):104-6. PubMed ID: 8576800
[No Abstract] [Full Text] [Related]
35. A pilot study of oral corticosteroid therapy for idiopathic esophageal ulcerations associated with human immunodeficiency virus infection.
Wilcox CM; Schwartz DA
Am J Med; 1992 Aug; 93(2):131-4. PubMed ID: 1497008
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
Jandourek A; Vaishampayan JK; Vazquez JA
AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
[TBL] [Abstract][Full Text] [Related]
37. Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome.
Tavitian A; Raufman JP; Rosenthal LE; Weber J; Webber CA; Dincsoy HP
Gastroenterology; 1986 Feb; 90(2):443-5. PubMed ID: 3510145
[TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of fluconazole].
Oka S; Tokitsu M; Mori H; Nakata H; Goto M; Goto H; Shimada K
Jpn J Antibiot; 1989 Jan; 42(1):31-9. PubMed ID: 2540365
[TBL] [Abstract][Full Text] [Related]
39. Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
Parente F; Cernuschi M; Rizzardini G; Lazzarin A; Valsecchi L; Bianchi Porro G
Am J Gastroenterol; 1991 Dec; 86(12):1729-34. PubMed ID: 1962617
[TBL] [Abstract][Full Text] [Related]
40. [Secondary prevention of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome].
Lavilla Uriol P; Gil A; Valencia E; Pintado V; López Dupla M; Khamashta M; García Puig J; Ortiz Vázquez J
Rev Clin Esp; 1992 Feb; 190(3):115-9. PubMed ID: 1561451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
